Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Oligodendroglioma × Diphtheria-Tetanus Vaccine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Brain Neoplasms 2 Xanthomatosis, Cerebrotendinous 1 Oligodendroglioma 1 Melanoma 1 Influenza, Human 1 Advanced Fallopian Tube Carcinoma 1

Interventions

Temozolomide 41 Radiotherapy 20 Irinotecan 12 Carboplatin 11 Bevacizumab 11 Magnetic Resonance Spectroscopy 10 Filgrastim 9 Surgical Procedures, Operative 6 Procarbazine 6 sargramostim 5 Vincristine 5 Imatinib Mesylate 5 Etoposide 5 Erlotinib Hydrochloride 5 Carmustine 5 etoposide phosphate 4 Peripheral Blood Stem Cell Transplantation 4 Lomustine 4 Immunohistochemistry 4 Cyclophosphamide 4 Biopsy 4 temsirolimus 3 poly ICLC 3 Thalidomide 3 Surveys and Questionnaires 3 Radiation 3 Polymerase Chain Reaction 3 Gadolinium DTPA 3 Aminolevulinic Acid 3 sodium thiosulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06254326 2026-03-09

ADAGiO

University of Florida

Phase 1 Active not recruiting

Brain Neoplasms, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡